Ming Yao

Publications
Grants
CV
Public outreach and news

Articles

Article: CELL TRANSPLANTATION. 2024;33:9636897241256462
Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Guisti Coitinho P; Lundgren T; Agren N; Ericzon B-G; Kumagai-Braesch M
Journal article: TRANSPLANTATION. 2022;106(9S):s153-s154
245.2: Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors Adjacent to Organ Procurement for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Coitinho PG; Lundgren T; Ågren N; Ericzon B-G; Kumagai-Braesch M
Article: TRANSPLANT INTERNATIONAL. 2021;34(12):2816-2823
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation
Bergstrom M; Yao M; Muller M; Korsgren O; Von Zur-Muhlen B; Lundgren T
Article: CELL TRANSPLANTATION. 2021;30:9636897211039739
Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation
Yao M; Domogatskaya A; Agren NI; Watanabe M; Tokodai K; Brines M; Cerami A; Ericzon B-G; Kumagai-Braesch M; Lundgren T
Article: TRANSPLANTATION. 2020;104(10):2048-2058
Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand
Yao M; Watanabe M; Sun S; Tokodai K; Cerami A; Brines M; Ostenson C-G; Ericzon B-G; Lundgren T; Kumagai-Braesch M
Article: WORLD JOURNAL OF SURGERY. 2020;44(6):1954-1965
Impact of Hepatic Artery Variations and Reconstructions on the Outcome of Orthotopic Liver Transplantation
Karakoyun R; Romano A; Yao M; Dlugosz R; Ericzon B-G; Nowak G
Article: CELL TRANSPLANTATION. 2018;27(11):1692-1704
Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
Watanabe M; Kumagai-Braesch M; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson SL; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon B-G
Journal article: JOURNAL OF DIABETES & METABOLISM. 2016;7(10):2-10
An Engineered Innate Repair Receptor Agonist, ARA 290, Protects Rat Islets from Cytokine-induced Apoptosis
Watanabe M; Saito Y; Wallmo J; Takahashi T; Diab RAH; Yao MH; Brines M; Cerami A; Ostenson C-G; Lundgren T; Kumagai-Braesch M

All other publications

Doctoral thesis: 2022
Targeting innate and adaptive immune responses to achieve long-term allograft acceptance following transplantation
Yao MH
Conference publication: TRANSPLANTATION. 2022;106(9):S153-S154
Evaluation of Methods to Obtain Peripheral Blood Mononuclear Cells From Deceased Donors Adjacent to Organ Procurement for Tolerance-Induction Protocols
Yao M; Henriksson J; Fahlander H; Coitinho PG; Lundgren T; Agren N; Ericzon B-G; Kumagai-Braesch M
Conference publication: TRANSPLANTATION. 2018;102:S747-S748
Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation Using Induction Treatment of the Non-Hematopoetic Erythropoietin Analogue Cibinetide in a Mouse Model
Yao MH; Waatanabe M; Sun S; Tokodai K; Cerami A; Brines M; Ericzon BG; Lundgren T; Kumagai-Braesch M
Meeting abstract: TRANSPLANTATION. 2018;102:s232
Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components
Yao MH; Kumagai-Braesch M; Watanabe M; Tokodai K; Lundgren T; Uhlin M; Ericzon BG
Conference publication: AMERICAN JOURNAL OF TRANSPLANTATION. 2017;17:424-425
Cibinetide (ARA 290), the Innate Repair Receptor Ligand, Improves Engraftment in Pancreatic Islet Transplantation by Protecting Islets and Reducing Inflammatory Reactions
Watanabe M; Yao MH; Zemack H; Ericzon B-G; Cerami A; Brines M; Lundgren T; Kumagai-Braesch M
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:1063
A Non-hematopoietic erythropoietin analogue, ARA 290, prolonged allogeneic islet graft survival in a mouse model
Watanabe M; Yao MH; Cerami A; Brines M; Ericzon B-G; Lundgren T; Kumagai-Braesch M
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:125
Ex vivo generation of alloantigen-specific T regulatory cells using selective T-cell costimulation blockade
Watanabe M; Kumagai-Braesch M; Thunberg S; Henrikson J; Sellberg F; Lundgren T; Yao MH; Jorns C; Berglund D; Berglund E; Ericzon B-G
Conference publication: TRANSPLANTATION. 2016;100(7):S463
Ex vivo generation of alloantigen-specific Immunomodulatory cells with co-stimulation blockade: do we need Treg purification for cell therapy?
Yao MH; Kumagai-Braesch M; Lundgren T; Andersson D; Ericzon B-G; Watanabe M
Conference publication: TRANSPLANTATION. 2016;100(7):S463-S464
A non-hematopoietic erythropoietin analogue, ARA 290, prolonged allogeneic islet graft survival in a mouse model
Watanabe M; Yao MH; Ericzon B-G; Cerami A; Brines M; Lundgren T; Kumagai-Braesch M
Conference publication: TRANSPLANTATION. 2015;99(11):S47
EX VIVO GENERATION OF ALLOANTIGEN-SPECIFIC T REGULATORY CELLS USING SELECTIVE T-CELL CO-STIMULATION BLOCKADE.
Watanabe M; Kumagai-Braesch M; Yao M; Berglund D; Jorns C; Thunberg S; Lind-Enoksson S; Henrikson J; Lundgren T; Sellberg F; Berglund E; Ericzon B-G

Grants

Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression
Swedish Research Council
1 January 2019 - 31 December 2021

Employments

Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2022
Degree Of Master Of Science In Medicine, Karolinska Institutet, 2015

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI